HLB Life Science Co., Ltd. (067630.KQ) KOE

3,890.00

+35(+0.91%)

Updated at December 05 12:13PM

Currency In KRW

Valuation

Market Cap1.13T
Enterprise Value1.2T
P/E Ratio-6.07
PEG Ratio-0.09
Price/Sales Ratio5
Price/Book Ratio1.5
Enterprise/Revenue6.19
Enterprise/EBITDA-55.37

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-0.83
Operating Margin-0.27

Management Effectiveness

Return On Assets-0.16
Return On Equity-0.21

Income Statement

Revenue102.24B
Revenue/Share768.92
Gross Profit-2.19B
EBITDA26.85B
Net Income6.14B
Diluted EPS54

Balance Sheet

Total Cash37.38B
Total Cash/Share305.76
Total Debt148.76B
Total Debt/Equity0.47
Current Ratio1.8
Book Value Per Share2,570.25

Price History

52-Week Change-61.37
52-Week High11,940
52-Week Low3,105
Moving Average 50 Days3,892.6
Moving Average 200 Days5,609.35

Statistics

Average Volume907,178
Shares Outstanding121.85M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor525849:500000
Last Split DateDecember 28, 2022